0001042187
false
Q2
--12-31
0.42
0.42
0001042187
2023-01-01
2023-06-30
0001042187
2023-08-01
0001042187
2023-06-30
0001042187
2022-12-31
0001042187
us-gaap:NonrelatedPartyMember
2023-06-30
0001042187
us-gaap:NonrelatedPartyMember
2022-12-31
0001042187
us-gaap:RelatedPartyMember
2023-06-30
0001042187
us-gaap:RelatedPartyMember
2022-12-31
0001042187
2023-04-01
2023-06-30
0001042187
2022-04-01
2022-06-30
0001042187
2022-01-01
2022-06-30
0001042187
2021-12-31
0001042187
2022-06-30
0001042187
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2021-12-31
0001042187
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2021-12-31
0001042187
us-gaap:SeriesCPreferredStockMember
us-gaap:PreferredStockMember
2021-12-31
0001042187
us-gaap:SeriesDPreferredStockMember
us-gaap:PreferredStockMember
2021-12-31
0001042187
us-gaap:CommonStockMember
2021-12-31
0001042187
us-gaap:AdditionalPaidInCapitalMember
2021-12-31
0001042187
us-gaap:RetainedEarningsMember
2021-12-31
0001042187
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-12-31
0001042187
us-gaap:TreasuryStockCommonMember
2021-12-31
0001042187
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2022-12-31
0001042187
us-gaap:CommonStockMember
2022-12-31
0001042187
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001042187
us-gaap:RetainedEarningsMember
2022-12-31
0001042187
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-12-31
0001042187
us-gaap:TreasuryStockCommonMember
2022-12-31
0001042187
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2022-01-01
2022-06-30
0001042187
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2022-01-01
2022-06-30
0001042187
us-gaap:SeriesCPreferredStockMember
us-gaap:PreferredStockMember
2022-01-01
2022-06-30
0001042187
us-gaap:SeriesDPreferredStockMember
us-gaap:PreferredStockMember
2022-01-01
2022-06-30
0001042187
us-gaap:CommonStockMember
2022-01-01
2022-06-30
0001042187
us-gaap:AdditionalPaidInCapitalMember
2022-01-01
2022-06-30
0001042187
us-gaap:RetainedEarningsMember
2022-01-01
2022-06-30
0001042187
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-01-01
2022-06-30
0001042187
us-gaap:TreasuryStockCommonMember
2022-01-01
2022-06-30
0001042187
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2023-01-01
2023-06-30
0001042187
us-gaap:CommonStockMember
2023-01-01
2023-06-30
0001042187
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-06-30
0001042187
us-gaap:RetainedEarningsMember
2023-01-01
2023-06-30
0001042187
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-01-01
2023-06-30
0001042187
us-gaap:TreasuryStockCommonMember
2023-01-01
2023-06-30
0001042187
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2022-06-30
0001042187
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2022-06-30
0001042187
us-gaap:SeriesCPreferredStockMember
us-gaap:PreferredStockMember
2022-06-30
0001042187
us-gaap:SeriesDPreferredStockMember
us-gaap:PreferredStockMember
2022-06-30
0001042187
us-gaap:CommonStockMember
2022-06-30
0001042187
us-gaap:AdditionalPaidInCapitalMember
2022-06-30
0001042187
us-gaap:RetainedEarningsMember
2022-06-30
0001042187
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-06-30
0001042187
us-gaap:TreasuryStockCommonMember
2022-06-30
0001042187
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2023-06-30
0001042187
us-gaap:CommonStockMember
2023-06-30
0001042187
us-gaap:AdditionalPaidInCapitalMember
2023-06-30
0001042187
us-gaap:RetainedEarningsMember
2023-06-30
0001042187
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-06-30
0001042187
us-gaap:TreasuryStockCommonMember
2023-06-30
0001042187
2021-09-29
2023-06-30
0001042187
CTIB:PNCAgreementsMember
CTIB:PNCMember
CTIB:TermLoanMember
2021-09-30
0001042187
CTIB:LineFinancialAgreementMember
CTIB:LineFinancialMember
CTIB:TermLoanMember
2021-09-30
0001042187
CTIB:LineFinancialAgreementMember
us-gaap:PrimeRateMember
2023-03-31
0001042187
CTIB:LineFinancialAgreementMember
us-gaap:PrimeRateMember
2023-03-30
2023-03-31
0001042187
CTIB:LineFinancialAgreementMember
2023-03-31
0001042187
CTIB:LineFinancialAgreementMember
2021-11-01
2021-11-01
0001042187
CTIB:LineFinancialAgreementMember
2021-09-01
2021-09-30
0001042187
CTIB:LineFinancialAgreementMember
2021-09-30
0001042187
CTIB:LineFinancialAgreementMember
2022-08-01
2022-08-31
0001042187
2021-12-30
2021-12-31
0001042187
2021-09-01
2021-09-30
0001042187
CTIB:TermLoanMember
2023-06-30
0001042187
CTIB:JohnHSchwanMember
2019-01-01
0001042187
CTIB:JohnHSchwanMember
2018-12-30
2019-01-01
0001042187
CTIB:JohnHSchwanMember
us-gaap:CommonStockMember
2018-12-30
2019-01-01
0001042187
CTIB:JohnHSchwanMember
us-gaap:CommonStockMember
2019-01-01
0001042187
CTIB:PromissoryNoteMember
CTIB:JohnHSchwanMember
2023-06-30
0001042187
CTIB:PromissoryNoteMember
CTIB:JohnHSchwanMember
2022-12-31
0001042187
CTIB:PromissoryNoteMember
us-gaap:RelatedPartyMember
2023-04-01
2023-06-30
0001042187
CTIB:PromissoryNoteMember
us-gaap:RelatedPartyMember
2022-04-01
2022-06-30
0001042187
CTIB:AlexFengMember
2022-12-31
0001042187
CTIB:AlexFengMember
2022-01-01
2022-12-31
0001042187
CTIB:StockPurchaseAgreementMember
us-gaap:SeriesAPreferredStockMember
2020-01-02
2020-01-03
0001042187
CTIB:StockPurchaseAgreementMember
us-gaap:SeriesAPreferredStockMember
2020-01-03
0001042187
us-gaap:SeriesAPreferredStockMember
CTIB:AdditionalSharesOfferingMember
2020-01-02
2020-01-03
0001042187
us-gaap:SeriesAPreferredStockMember
us-gaap:InvestorMember
2020-01-02
2020-01-03
0001042187
us-gaap:CommonStockMember
CTIB:LFInternationalOfferingMember
2020-01-02
2020-01-03
0001042187
us-gaap:SeriesAPreferredStockMember
2020-01-02
2020-01-03
0001042187
us-gaap:SeriesAPreferredStockMember
2020-01-03
0001042187
us-gaap:SeriesAPreferredStockMember
2023-04-01
2023-06-30
0001042187
us-gaap:SeriesAPreferredStockMember
2022-04-01
2022-06-30
0001042187
us-gaap:CommonStockMember
CTIB:ConvertibleSeriesAPreferredStockMember
2022-09-01
0001042187
us-gaap:CommonStockMember
CTIB:ConvertibleSeriesAPreferredStockMember
2022-09-01
2022-09-01
0001042187
us-gaap:SeriesBPreferredStockMember
2020-11-01
2020-11-30
0001042187
us-gaap:SeriesBPreferredStockMember
2020-11-30
0001042187
us-gaap:SeriesBPreferredStockMember
2023-06-30
0001042187
us-gaap:SeriesBPreferredStockMember
2022-12-31
0001042187
us-gaap:CommonStockMember
CTIB:ConvertibleSeriesCPreferredStockMember
2023-02-01
0001042187
us-gaap:SeriesCPreferredStockMember
2021-01-01
2021-01-31
0001042187
us-gaap:SeriesCPreferredStockMember
2021-01-31
0001042187
us-gaap:CommonStockMember
CTIB:ConvertibleSeriesCPreferredStockMember
2022-09-01
0001042187
CTIB:UnrelatedThirdPartyMember
us-gaap:SeriesDPreferredStockMember
2021-06-01
2021-06-30
0001042187
us-gaap:SeriesDPreferredStockMember
2021-09-29
2021-09-30
0001042187
us-gaap:SeriesDPreferredStockMember
2021-12-30
2021-12-31
0001042187
us-gaap:SeriesDPreferredStockMember
2021-12-31
0001042187
us-gaap:SeriesDPreferredStockMember
2021-01-01
2021-12-31
0001042187
us-gaap:CommonStockMember
CTIB:ConvertibleSeriesDPreferredStockMember
2022-09-01
0001042187
2022-12-31
2022-12-31
0001042187
2023-02-01
2023-02-01
0001042187
2023-04-01
2023-04-30
0001042187
2020-12-31
0001042187
2020-01-01
2020-12-31
0001042187
2021-02-28
0001042187
2021-01-01
2021-02-28
0001042187
us-gaap:SeriesDPreferredStockMember
2021-02-28
0001042187
2021-01-01
2021-12-31
0001042187
srt:ChiefExecutiveOfficerMember
us-gaap:RestrictedStockMember
2022-01-01
2022-01-31
0001042187
srt:ChiefExecutiveOfficerMember
us-gaap:RestrictedStockMember
2022-01-31
0001042187
srt:ChiefExecutiveOfficerMember
us-gaap:RestrictedStockMember
CTIB:TrailingTwelveMonthEBITDAEqualsOrExceedsOneMillionMember
2022-01-30
2022-01-30
0001042187
srt:ChiefExecutiveOfficerMember
us-gaap:RestrictedStockMember
CTIB:CommonSharesTradeAtOrAbove5shareForTenOrMoreConsecutiveTradingDaysMember
2022-01-30
2022-01-30
0001042187
srt:ChiefExecutiveOfficerMember
us-gaap:RestrictedStockMember
CTIB:OperatingCashFlowCalculatedCumulativelyFromTheDateOfEmploymentEqualsOrExceeds15MillionMember
2022-01-30
2022-01-30
0001042187
srt:ChiefExecutiveOfficerMember
us-gaap:RestrictedStockMember
CTIB:CompanyIsAbleToRefinanceItsCurrentLenderWithATraditionalLenderMember
2022-01-30
2022-01-30
0001042187
us-gaap:RestrictedStockMember
srt:ChiefOperatingOfficerMember
2022-12-31
0001042187
us-gaap:RestrictedStockMember
srt:ChiefOperatingOfficerMember
2022-01-01
2022-12-31
0001042187
us-gaap:RestrictedStockMember
2022-01-01
2022-12-31
0001042187
us-gaap:WarrantMember
2022-12-31
0001042187
us-gaap:WarrantMember
2023-01-01
2023-06-30
0001042187
us-gaap:WarrantMember
2023-06-30
0001042187
CTIB:TwoThousandAndTwentyOneWarrantsMember
2023-06-30
0001042187
CTIB:CustomersAMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2023-06-30
0001042187
CTIB:CustomersAMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2023-01-01
2023-06-30
0001042187
CTIB:CustomersAMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2022-06-30
0001042187
CTIB:CustomersAMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2022-01-01
2022-06-30
0001042187
CTIB:CustomerAMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2023-04-01
2023-06-30
0001042187
CTIB:CustomerAMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2022-04-01
2022-06-30
0001042187
CTIB:CustomerBMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2023-04-01
2023-06-30
0001042187
CTIB:CustomerBMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2022-04-01
2022-06-30
0001042187
CTIB:CustomerAMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2023-01-01
2023-06-30
0001042187
CTIB:CustomerAMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2022-01-01
2022-06-30
0001042187
CTIB:CustomerBMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2023-01-01
2023-06-30
0001042187
CTIB:CustomerBMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2022-01-01
2022-06-30
0001042187
us-gaap:RelatedPartyMember
2022-06-30
0001042187
CTIB:JohnHSchwanMember
2023-01-01
2023-06-30
0001042187
us-gaap:RelatedPartyMember
2023-04-01
2023-06-30
0001042187
us-gaap:RelatedPartyMember
2022-04-01
2022-06-30
0001042187
CTIB:LeaseAgreementMember
2020-07-01
2020-07-31
0001042187
CTIB:LeaseAgreementMember
2023-01-01
2023-06-30
0001042187
CTIB:LeaseAgreementMember
2023-06-30
0001042187
CTIB:LeaseAgreementMember
2022-03-31
0001042187
CTIB:LeaseAgreementMember
2021-12-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
CTIB:Integer
CTIB:Customers
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
10-Q
(Mark
One)
☒ |
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For
the quarterly period ended June 30, 2023
OR
☐ |
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For
the transition period from _________to_________
Commission
File Number
000-23115
YUNHONG
CTI LTD.
(Exact
name of registrant as specified in its charter)
Illinois |
|
36-2848943 |
(State
or other jurisdiction of |
|
(I.R.S.
Employer |
incorporation
or organization) |
|
Identification
No.) |
22160
N. Pepper Road |
|
|
Barrington,
Illinois |
|
60010 |
(Address
of principal executive offices) |
|
(Zip
Code) |
(847)382-1000
(Registrant’s
telephone number, including area code)
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Common
Stock, no par value per share |
|
CTIB |
|
The
Nasdaq Stock Market LLC
(The
Nasdaq Capital Market) |
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large
accelerated filer |
☐ |
Accelerated
filer |
☐ |
Non-accelerated
filer |
☒ |
Smaller
reporting company |
☒ |
|
|
Emerging
growth company |
☐ |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The
number of shares outstanding of the registrant’s common stock, no par value per share, as of August 1, 2023 was 20,096,755 (excluding
treasury shares).
INDEX
Yunhong
CTI, LTD |
Condensed
Consolidated Balance Sheets |
| |
June
30, 2023 | | |
December
31, 2022 | |
ASSETS | |
| | | |
| | |
Current
assets: | |
| | | |
| | |
Cash
and cash equivalents | |
$ | 100,000 | | |
$ | 146,000 | |
Accounts
receivable, net | |
| 2,959,000 | | |
| 1,618,000 | |
Inventories,
net | |
| 7,639,000 | | |
| 8,325,000 | |
Prepaid
expenses | |
| 436,000 | | |
| 389,000 | |
| |
| | | |
| | |
Total
current assets | |
| 11,134,000 | | |
| 10,478,000 | |
| |
| | | |
| | |
Property,
plant and equipment: | |
| | | |
| | |
Machinery
and equipment | |
| 17,723,000 | | |
| 17,723,000 | |
Office
furniture and equipment | |
| 2,084,000 | | |
| 2,084,000 | |
Intellectual
property | |
| 783,000 | | |
| 783,000 | |
Leasehold
improvements | |
| 39,000 | | |
| 39,000 | |
Fixtures
and equipment at customer locations | |
| 519,000 | | |
| 519,000 | |
Projects
under construction | |
| 202,000 | | |
| 108,000 | |
Property, plant and equipment, gross | |
| 21,350,000 | | |
| 21,256,000 | |
Less
: accumulated depreciation and amortization | |
| (20,485,000 | ) | |
| (20,334,000 | ) |
| |
| | | |
| | |
Total
property, plant and equipment, net | |
| 865,000 | | |
| 922,000 | |
| |
| | | |
| | |
Other
assets: | |
| | | |
| | |
Operating
lease right-of-use | |
| 3,628,000 | | |
| 3,882,000 | |
| |
| | | |
| | |
Total
other assets | |
| 3,628,000 | | |
| 3,882,000 | |
| |
| | | |
| | |
TOTAL
ASSETS | |
$ | 15,627,000 | | |
$ | 15,282,000 | |
| |
| | | |
| | |
LIABILITIES
AND SHAREHOLDERS’ EQUITY | |
| | | |
| | |
Current
liabilities: | |
| | | |
| | |
Trade
payables | |
$ | 982,000 | | |
$ | 1,313,000 | |
Line
of credit | |
| 4,288,000 | | |
| 2,878,000 | |
Notes
payable - current portion | |
| 521,000 | | |
| 289,000 | |
Notes
payable – related party, subordinated | |
| 1,305,000 | | |
| - | |
Notes
payable | |
| 1,305,000 | | |
| - | |
Operating
Lease Liabilities | |
| 519,000 | | |
| 518,000 | |
Accrued
liabilities | |
| 1,014,000 | | |
| 2,480,000 | |
| |
| | | |
| | |
Total
current liabilities | |
| 8,629,000 | | |
| 7,478,000 | |
Long-term
liabilities: | |
| | | |
| | |
Notes
payable - noncurrent | |
| - | | |
| 427,000 | |
Notes
payable – related party, subordinated | |
| - | | |
| 1,267,000 | |
Notes
payable | |
| - | | |
| 1,267,000 | |
Operating
Lease Liabilities – noncurrent | |
| 3,109,000 | | |
| 3,364,000 | |
Total
long-term liabilities | |
| 3,109,000 | | |
| 5,058,000 | |
| |
| | | |
| | |
TOTAL
LIABILITIES | |
| 11,738,000 | | |
| 12,536,000 | |
| |
| | | |
| | |
Equity: | |
| | | |
| | |
Yunhong
CTI, Ltd stockholders’ equity: | |
| | | |
| | |
Series
B Preferred Stock — no par value, 170,000 shares authorized, none and 170,000 issued and outstanding at June 30, 2023 and December
31, 2022, respectively | |
| - | | |
| 1,851,000 | |
Common
Stock – no par value, 50,000,000 shares authorized, 20,140,413 and 16,102,749 shares issued and 20,096,755 and 16,059,991 shares
outstanding at June 30, 2023 and December 31, 2022, respectively | |
| 21,283,000 | | |
| 21,283,000 | |
Paid-in-capital | |
| 6,642,000 | | |
| 3,895,000 | |
Accumulated
deficit | |
| (23,875,000 | ) | |
| (24,122,000 | ) |
Less:
Treasury stock, 43,658 shares | |
| (161,000 | ) | |
| (161,000 | ) |
| |
| | | |
| | |
Total
Yunhong CTI, Ltd Stockholders’ Equity | |
| 3,889,000 | | |
| 2,746,000 | |
| |
| | | |
| | |
TOTAL
LIABILITIES AND SHAREHOLDERS’ EQUITY | |
$ | 15,627,000 | | |
$ | 15,282,000 | |
See
accompanying notes to condensed consolidated unaudited financial statements |
Yunhong
CTI, LTD |
Condensed
Consolidated Statements of Comprehensive Income (Loss) (Unaudited) |
| |
2023 | | |
2022 | | |
2023 | | |
2022 | |
| |
For
the Three Months Ended June 30, | | |
For
the Six Months Ended June 30, | |
| |
2023 | | |
2022 | | |
2023 | | |
2022 | |
| |
| | |
| | |
| | |
| |
Net
Sales | |
$ | 4,059,000 | | |
$ | 4,418,000 | | |
$ | 9,110,000 | | |
$ | 10,215,000 | |
| |
| | | |
| | | |
| | | |
| | |
Cost
of Sales | |
| 3,545,000 | | |
| 3,615,000 | | |
| 7,469,000 | | |
| 8,373,000 | |
| |
| | | |
| | | |
| | | |
| | |
Gross
profit | |
| 514,000 | | |
| 803,000 | | |
| 1,641,000 | | |
| 1,842,000 | |
| |
| | | |
| | | |
| | | |
| | |
Operating
expenses: | |
| | | |
| | | |
| | | |
| | |
General
and administrative | |
| 656,000 | | |
| 998,000 | | |
| 1,617,000 | | |
| 1,835,000 | |
Selling | |
| 33,000 | | |
| 34,000 | | |
| 65,000 | | |
| 72,000 | |
Advertising
and marketing | |
| 115,000 | | |
| 77,000 | | |
| 237,000 | | |
| 260,000 | |
| |
| | | |
| | | |
| | | |
| | |
Total
operating (income) expenses | |
| 804,000 | | |
| 1,109,000 | | |
| 1,919,000 | | |
| 2,167,000 | |
| |
| | | |
| | | |
| | | |
| | |
Loss
from operations | |
| (290,000 | ) | |
| (306,000 | ) | |
| (278,000 | ) | |
| (325,000 | ) |
| |
| | | |
| | | |
| | | |
| | |
Other
(expense) income: | |
| | | |
| | | |
| | | |
| | |
Interest
expense | |
| (155,000 | ) | |
| (109,000 | ) | |
| (297,000 | ) | |
| (205,000 | ) |
Other
income/(expense) | |
| 296,000 | | |
| 16,000 | ) | |
| 822,000 | | |
| 110,000 | ) |
| |
| | | |
| | | |
| | | |
| | |
Total
other expense, net | |
| 141,000 | | |
| (93,000 | ) | |
| 525,000 | | |
| (95,000 | ) |
| |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | |
Income
tax expense | |
| - | | |
| - | | |
| - | | |
| - | |
| |
| | | |
| | | |
| | | |
| | |
Income
(Loss) from continuing operations | |
| (149,000 | ) | |
| (399,000 | ) | |
| 247,000 | | |
| (420,000 | ) |
| |
| | | |
| | | |
| | | |
| | |
Less:
Net income attributable to noncontrolling interest | |
| - | | |
| - | | |
| - | | |
| - | |
| |
| | | |
| | | |
| | | |
| | |
Net
(loss) / income attributable to Yunhong CTI, Ltd | |
$ | (149,000 | ) | |
$ | (399,000 | | |
$ | 247,000 | | |
$ | (420,000 | |
| |
| | | |
| | | |
| | | |
| | |
Other
Comprehensive Income (Loss) | |
| | | |
| | | |
| | | |
| | |
Foreign
currency adjustment | |
| - | | |
| - | | |
| - | | |
| - | |
Comprehensive
(loss) / income | |
$ | (149,000 | ) | |
$ | (399,000 | | |
$ | 247,000 | | |
$ | (420,000 | |
| |
| | | |
| | | |
| | | |
| | |
Deemed
Dividends on preferred stock and amortization of beneficial conversion feature | |
$ | - | | |
$ | (202,000 | ) | |
$ | (11,000 | ) | |
$ | (404,000 | ) |
| |
| | | |
| | | |
| | | |
| | |
Net
(Loss) / income attributable to Yunhong CTI Ltd common Shareholders | |
$ | (149,000 | ) | |
$ | (601,000 | ) | |
$ | 236,000 | | |
$ | (824,000 | ) |
| |
| | | |
| | | |
| | | |
| | |
Basic
(loss) / income per common share | |
| | | |
| | | |
| | | |
| | |
Continuing
operations | |
$ | (0.01 | ) | |
$ | (0.10 | ) | |
$ | 0.01 | | |
$ | (0.14 | ) |
Discontinued
operations | |
| - | | |
| - | | |
| - | | |
| - | |
Basic
(loss) / income per common share | |
$ | (0.01 | ) | |
$ | (0.10 | ) | |
$ | 0.01 | | |
$ | (0.14 | ) |
| |
| | | |
| | | |
| | | |
| | |
Diluted
(loss) / income per common share | |
| | | |
| | | |
| | | |
| | |
Continuing
operations | |
$ | (0.01 | ) | |
$ | (0.10 | ) | |
$ | 0.01 | | |
$ | (0.14 | ) |
Discontinued
operations | |
| - | | |
| - | | |
| - | | |
| - | |
Diluted
(loss) / income per common share | |
$ | (0.01 | ) | |
$ | (0.10 | ) | |
$ | 0.01 | | |
$ | (0.14 | ) |
| |
| | | |
| | | |
| | | |
| | |
Weighted
average number of shares and equivalent shares of common stock outstanding: | |
| | | |
| | | |
| | | |
| | |
Basic | |
| 20,034,941 | | |
| 5,911,750 | | |
| 18,822,352 | | |
| 5,906,225 | |
| |
| | | |
| | | |
| | | |
| | |
Diluted | |
| 20,034,941 | | |
| 5,911,750 | | |
| 18,822,352 | | |
| 5,906,225 | |
See
accompanying notes to condensed consolidated unaudited financial statements |
Yunhong
CTI, LTD |
Condensed
Consolidated Statements of Cash Flows (Unaudited) |
| |
2023 | | |
2022 | |
| |
For
the Six Months Ended June 30, | |
| |
2023 | | |
2022 | |
| |
| | |
| |
Cash
flows from operating activities: | |
| | | |
| | |
Net
income / (loss) from continuing operations | |
$ | 247,000 | | |
$ | (420,000 | ) |
Adjustments
to reconcile net loss to net cash (used in) provided by operating activities: | |
| | | |
| | |
Depreciation
and amortization | |
| 151,000 | | |
| 195,000 | |
Equity
compensation expense | |
| 11,000 | | |
| 92,000 | |
Change
in assets and liabilities: | |
| | | |
| | |
Accounts
receivable | |
| (1,341,000 | ) | |
| 707,000 | |
Inventories | |
| 686,000 | | |
| (405,000 | ) |
Prepaid
expenses and other assets | |
| (47,000 | ) | |
| 333,000 | |
Trade
payables | |
| (331,000 | ) | |
| (112,000 | ) |
Accrued
liabilities | |
| (737,000 | ) | |
| (87,000 | ) |
| |
| | | |
| | |
Net
cash provided by (used in) operating activities | |
| (1,361,000 | ) | |
| 303,000 | |
| |
| | | |
| | |
Cash
flows from investing activities: | |
| | | |
| | |
Purchases
of property, plant and equipment | |
| (94,000 | ) | |
| (94,000 | ) |
| |
| | | |
| | |
Net
cash (used in) provided by investing activities | |
| (94,000 | ) | |
| (94,000 | ) |
| |
| | | |
| | |
Cash
flows from financing activities: | |
| | | |
| | |
Proceeds
from issuance/(Repayment) of long-term debt and revolving line of credit | |
| 1,409,000 | | |
| (221,000 | ) |
| |
| | | |
| | |
Net
cash used in financing activities | |
| 1,409,000 | | |
| (221,000 | ) |
| |
| | | |
| | |
Net
(decrease) / increase in cash and cash equivalents | |
| (46,000 | ) | |
| (12,000 | ) |
| |
| | | |
| | |
Cash
and cash equivalents at beginning of period | |
| 146,000 | | |
| 66,000 | |
| |
| | | |
| | |
Cash
and cash equivalents at end of period | |
$ | 100,000 | | |
$ | 54,000 | |
| |
| | | |
| | |
Supplemental
disclosure of cash flow information: | |
| | | |
| | |
Cash
payments for interest | |
$ | 259,000 | | |
$ | 169,000 | |
Accrued
Divided and Accretion on preferred stock | |
$ | 11,000 | | |
$ | 404,000 | |
Lease
right-of-use assets and lease liability | |
$ | - | | |
$ | 747,000 | |
Conversion
of notes and deposits into common stock | |
$ | 885,000 | | |
$ | - | |
Conversion
of Series B preferred stock into common stock | |
$ | 1,500,000 | | |
$ | - | |
See
accompanying notes to condensed consolidated unaudited financial statements |
Yunhong
CTI, Ltd |
Consolidated
Statements of Stockholders’ Equity |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Earnings | | |
Shares | | |
Amount | | |
TOTAL | |
| |
Yunhong
CTI, Ltd | | |
| |
| |
Series
A Preferred Stock | | |
Series
B Preferred Stock | | |
Series
C Preferred Stock | | |
Series
D Preferred Stock | | |
Common
Stock | | |
Paid-in | | |
Accumulated (Deficit) | | |
Less
Treasury
Stock | | |
| |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Earnings | | |
Shares | | |
Amount | | |
TOTAL | |
| |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
Balance
December 31, 2021 | |
| 500,000 | | |
$ | 3,155,000 | | |
| 170,000 | | |
$ | 1,715,000 | | |
| 170,000 | | |
$ | 1,630,000 | | |
| 170,000 | | |
$ | 1,512,000 | | |
| 5,930,408 | | |
$ | 14,538,000 | | |
$ | 4,317,000 | | |
$ | (22,655,000 | ) | - |
| (44,000 | ) | |
$ | (161,000 | ) | |
| 4,051,000 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Accrued
Deemed Dividend - Series A Preferred Stock | |
| | | |
| 200,000 | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| (200,000 | ) | |
| | | |
| - | | |
| - | | |
| - | |
Accrued
Deemed Dividend - Series B Preferred Stock | |
| | | |
| | | |
| | | |
| 68,000 | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| (68,000 | ) | |
| | | |
| | | |
| | | |
| - | |
Accrued
Deemed Dividend - Series C Preferred Stock | |
| | | |
| | | |
| | | |
| | | |
| | | |
| 68,000 | | |
| | | |
| | | |
| | | |
| | | |
| (68,000 | ) | |
| | | |
| | | |
| | | |
| - | |
Accrued
Deemed Dividend - Series D Preferred Stock | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| 68,000 | | |
| | | |
| | | |
| (68,000 | ) | |
| | | |
| | | |
| | | |
| - | |
Stock
Issuance | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| 25,000 | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| - | |
Equity
Compensation Charge | |
| | | |
| - | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| 92,000 | | |
| | | |
| - | | |
| - | | |
| 92,000 | |
Net
Income (Loss) | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| (420,000 | ) | - |
| | | |
| | | |
| (420,000 | ) |
Balance
June 30, 2022 | |
| 500,000 | | |
$ | 3,355,000 | | |
| 170,000 | | |
$ | 1,783,000 | | |
| 170,000 | | |
$ | 1,698,000 | | |
| 170,000 | | |
$ | 1,580,000 | | |
| 5,955,408 | | |
$ | 14,538,000 | | |
$ | 4,005,000 | | |
$ | (23,075,000 | ) | - |
| (44,000 | ) | |
$ | (161,000 | ) | |
| 3,723,000 | |
Yunhong
CTI, Ltd |
Consolidated
Statements of Stockholders’ Equity |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Earnings | | |
Loss | | |
Shares | | |
Amount | | |
TOTAL | |
| |
Yunhong
CTI, Ltd | | |
| |
| |
| | |
| | |
| | |
| | |
| | |
| | |
Accumulated | | |
| | |
| |
| |
Series
B Preferred Stock | | |
Common
Stock | | |
Paid-in | | |
Accumulated
(Deficit) | | |
Other
Comprehensive | | |
Less
Treasury
Stock | | |
| |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Earnings | | |
Loss | | |
Shares | | |
Amount | | |
TOTAL | |
| |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
Balance
December 31, 2022 | |
| 170,000 | | |
$ | 1,851,000 | | |
| 16,102,749 | | |
$ | 21,283,000 | | |
$ | 3,895,000 | | |
$ | (24,122,000 | ) | |
$ | - | | |
| (44,000 | ) | |
$ | (161,000 | ) | |
| 2,746,000 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Series
B Convertible Preferred Stock Issuance | |
| (170,000 | ) | |
| (1,862,000 | ) | |
| 1,888,078 | | |
| | | |
| 1,862,000 | | |
| | | |
| | | |
| | | |
| | | |
| - | |
Common
stock issued for notes payable and investor deposit | |
| | | |
| | | |
| 1,908,336 | | |
| | | |
| 884,000 | | |
| | | |
| | | |
| | | |
| | | |
| 884,000 | |
Accrued
Deemed Dividend - Series B Preferred Stock | |
| | | |
| 11,000 | | |
| | | |
| | | |
| (11,000 | ) | |
| | | |
| | | |
| | | |
| | | |
| - | |
Equity
compensation | |
| | | |
| | | |
| 116,250 | | |
| | | |
| 12,000 | | |
| | | |
| | | |
| | | |
| | | |
| 12,000 | |
Broker
issuance | |
| | | |
| | | |
| 125,000 | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Net
Income (Loss) | |
| | | |
| | | |
| | | |
| | | |
| | | |
| 247,000 | | |
| | | |
| | | |
| | | |
| 247,000 | |
Foreign
Currency Translation | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| - | | |
| - | | |
| - | | |
| - | |
Balance
June 30, 2023 | |
| - | | |
$ | - | | |
| 20,140,413 | | |
$ | 21,283,000 | | |
$ | 6,642,000 | | |
$ | (23,875,000 | ) | |
$ | - | | |
| (44,000 | ) | |
$ | (161,000 | ) | |
| 3,889,000 | |
See
accompanying notes to condensed consolidated unaudited financial statements |
Yunhong
CTI Ltd. and Subsidiaries
Notes
to Unaudited Condensed Consolidated Financial Statements
Note
1 - Basis of Presentation
The
accompanying condensed (a) consolidated balance sheet as of June 30, 2023 and (b) the unaudited interim condensed consolidated financial
statements have been prepared and, in the opinion of management, contain all the adjustments (consisting of those of a normal recurring
nature) considered necessary to present fairly the consolidated financial position and the consolidated statements of comprehensive income
and consolidated cash flows for the periods presented in conformity with generally accepted accounting principles for interim consolidated
financial information and the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all the information
and footnotes required by accounting principles generally accepted in the United States of America. Operating results for the three and
six months ended June 30, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending December
31, 2023. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial
statements and notes thereto included in the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2022,
filed on April 15, 2023, which can be found on the Company’s website (www.ctiindustries.com) or www.sec.gov.
Principles
of consolidation and nature of operations:
Yunhong
CTI Ltd and CTI Supply, Inc. (collectively, the “Company”) (i) design, manufacture and distribute metalized balloon products
throughout the world, including balloon-inspired gift items, (ii) distribute purchased latex balloons products, and (iii) operate systems
for the production, lamination, coating and printing of films used for food packaging and other commercial uses and for conversion of
films to flexible packaging containers and other products.
The
condensed consolidated financial statements include the accounts of Yunhong CTI Ltd., and CTI Supply, Inc.
The
determination of whether or not to consolidate a variable interest entity under U.S. GAAP requires a significant amount of judgment concerning
the degree of control over an entity by its holders of variable interest. To make these judgments, management has conducted an analysis
of the relationship of the holders of variable interest to each other, the design of the entity, the expected operations of the entity,
which holder of variable interests is most “closely associated” to the entity and which holder of variable interests is the
primary beneficiary required to consolidate the entity. Upon the occurrence of certain events, management reviews and reconsiders its
previous conclusion regarding the status of an entity as a variable interest entity.
Reclassification:
Certain
amounts in the Company’s condensed consolidated financial statements for prior periods have been reclassified to conform to the
current period presentation. These reclassifications have not changed the results of operations of prior periods.
Use
of estimates:
In
preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management
makes estimates and assumptions that affect the amounts reported of assets and liabilities, disclosure of contingent assets and liabilities
at the date of the financial statements and the reported amount of revenues and expenses during the reporting period in the financial
statements and accompanying notes. Actual results may differ from those estimates. The Company’s significant estimates include
valuation allowances for doubtful accounts and inventory valuation, preferred stock dividends and beneficial conversion features, and
assumptions used as inputs in the Black-Scholes option-pricing model.
Segments:
The
Company operates as a single segment, both in terms of geography and operations, particularly in light of the October 2021 sale of its
Flexo Universal subsidiary (Mexico). After that date, all manufacturing occurs in the United States.
Earnings
per share:
Basic
income (loss) per share is computed by dividing net income (loss) attributable to Yunhong CTI Ltd shareholders by the weighted average
number of shares of common stock outstanding during each period.
Diluted
income (loss) per share is computed by dividing the net income (loss) attributable to Yunhong CTI Ltd shareholders by the weighted average
number of shares of common stock and equivalents (stock options and warrants), unless anti-dilutive, during each period.
As
of June 30, 2023 and 2022, shares to be issued upon the exercise of options and warrants aggregated 128,000 and none, respectively.
Significant
Accounting Policies:
The
Company’s significant accounting policies are summarized in Note 2 of the Company’s consolidated financial statements for
the year ended December 31, 2022. There were no significant changes to these accounting policies during the three and six months ended
June 30, 2023.
Net
sales include revenues from sales of products and shipping and handling charges, net of estimates for product returns. Revenue is measured
at the amount of consideration the Company expects to receive in exchange for the transferred products. Revenue is recognized at the
point in time when we transfer the promised products to the customer and the customer obtains control over the products. The Company
recognizes revenue for shipping and handling charges at the time the goods are shipped to the customer, and the costs of outbound freight
are included in cost of sales, as we have elected the practical expedient included in ASC 606.
The
Company provides for product returns based on historical return rates. While we incur costs for sales commissions to our sales employees
and outside agents, we recognize commission costs concurrent with the related revenue, as the amortization period is less than one year
and we have elected the practical expedient included in ASC 606. We do not incur incremental costs to obtain contracts with our customers.
Our product warranties are assurance-type warranties, which promise the customer that the products are as specified in the contract.
Therefore, the product warranties are not a separate performance obligation and are accounted for as described herein. Sales taxes assessed
by governmental authorities are accounted for on a net basis and are excluded from net sales.
Note
2 – Liquidity and Going Concern
The
Company’s financial statements are prepared using accounting principles generally accepted in the United States (“U.S. GAAP”)
applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business.
The Company has a cumulative net loss from inception to June 30, 2023 of approximately $23 million. The accompanying financial statements
for the three and six months ended June 30, 2023 have been prepared assuming the Company will continue as a going concern. The Company’s
cash resources from operations may be insufficient to meet its anticipated needs during the next twelve months. If the Company does not
execute its plan, it may require additional financing to fund its future planned operations.
The
ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses.
Management’s plans to continue as a going concern include raising additional capital through sales of equity securities and borrowing,
continuing to focus our Company on the most profitable elements, and exploring alternative funding sources on an as needed basis. However,
management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. The COVID-19 pandemic,
supply chain challenges, and inflationary pressures (including cost and availability of helium) have impacted the Company’s business
operations to some extent and is expected to continue to do so and these impacts may include reduced access to capital. The ability of
the Company to continue as a going concern may be dependent upon its ability to successfully secure other sources of financing and attain
profitable operations. There is substantial doubt about the ability of the Company to continue as a going concern for one year from the
issuance of the accompanying consolidated financial statements. The accompanying consolidated financial statements do not include any
adjustments that might be necessary if the Company is unable to continue as a going concern.
The
Company’s primary sources of liquidity have traditionally been comprised of cash and cash equivalents as well as availability under
the Credit Agreement in place at the time (see Note 3). We endured compliance failures with covenants until September 2021 when we refinanced
our credit facility. We believe we have been in compliance with our new credit facility since that time. This credit facility concludes
on September 30, 2023. While we expect to obtain a replacement facility on acceptable terms, there can be no assurance this will occur,
particularly in light of increasingly conservative financial markets.
Note
3 - Debt
On
September 30, 2021 (the “Closing Date”), the Company entered into a loan and security agreement (the “Agreement”)
with Line Financial (the “Lender”), which provides for a senior secured financing consisting of a revolving credit facility
(the “Revolving Credit Facility) in an aggregate principal amount of up to $6 million (the “Maximum Revolver Amount”)
and term loan facility (the “Term Loan Facility”) in an aggregate principal amount of $0.7 million (“Term Loan Amount”
and, together with the Revolving Credit Facility, the “Senior Facilities”). Proceeds of loans borrowed under the Senior Facilities
were used to repay all amounts outstanding under the Company’s previous lending agreements and for the Company’s working
capital. The Senior Facilities are secured by substantially all assets of the Company.
Interest
on the Senior Facilities shall be the prime rate published from time to time published in the Wall Street Journal (8% as of March 31,
2023), plus 1.95% per annum, accruing daily and payable monthly. Interest shall be calculated on the basis of a 360-day year for the
actual number of days elapsed. The Term Loan Facility shall be repaid by the Company to Lender in 48 equal monthly installments of principal
and interest, each in the amount of $15,000, commencing on November 1, 2021, and continuing on the first day of each month thereafter
until the Term Loan Maturity Date (as defined in the Agreement). Also, the Company paid the Lender collateral monitoring fees of 4.62%
of the eligible accounts receivable, inventory, and equipment supporting the Revolving Credit Facility and the Term Loan. In addition,
the Company paid the Lender a loan fee of 1.25% of the Maximum Revolver Amount and the Term Loan Amount upon the execution of the Agreement.
During August 2022 the terms were modified to reduce the collateral monitoring fee to 2.77% and added a provision that barred the Company
from repaying the facility prior to September 2023.
The
Senior Facilities mature on September 30, 2023 and shall automatically be extended for successive periods of one year each, unless the
Company or the Lender gives the other party written notice of termination not less than 90 days prior to the end of such term or renewal
term, as applicable. If the Senior Facilities are renewed, the Company shall pay the Lender a renewal fee of 1.25% of the Maximum Revolver
Amount and the Term Loan Amount upon each renewal on the anniversary of the Closing Date. The Company has the option to prepay the Term
Loan Facility (together with all accrued but unpaid interest and a Term Loan Prepayment Fee (as defined the Agreement) in whole, but
not in part, upon not less than 60 days prior written notice to the Lender. The Company is currently working on having a facility in
place upon the expiration of the current facility.
The
Senior Facilities require that the Company shall, commencing December 31, 2021, maintain Tangible Net Worth of at least $4,000,000 or
greater (“Minimum Tangible Net Worth”). Minimum Tangible Net Worth may be adjusted downward by the Lender, from time to time,
in its sole and absolute discretion, based on the effect of non-cash charges and other factors on the calculation of Tangible Net Worth.
Other debt subordinated to Lender is not considered as a reduction of this calculation. The Company believes it was in compliance with
this covenant for all relevant months, including as of June 30, 2023 and December 31, 2022, respectively.
The
Senior Facilities contain certain affirmative and negative covenants that limit the ability of the Company, among other things and subject
to certain significant exceptions, to incur debt or liens, make investments, enter into certain mergers, consolidations, and acquisitions,
pay dividends and make other restricted payments, or make capital expenditures exceeding $1,000,000 in the aggregate in any fiscal year.
As
of June 30, 2023, the term loan balance amounted to $0.5 million, which consisted of the principal and interest payable balance of $0.6
million and deferred financing costs of less than $0.1 million. The balance of the Revolving Line of Credit as of June 30, 2023 and December
31, 2022 amounted to $4,288,000 and $2,878,000, respectively.
As
of January 1, 2019, the Company had a note payable to John H. Schwan, former Director and former Chairman of the Board, for $1.6 million,
including accrued interest. This loan accrues interest, is due December 31, 2023, and is subordinate to the Senior Facilities. During
January 2019, Mr. Schwan converted $600,000 of the note into approximately 181,000 shares of our common stock at the then market rate
of $3.32 per share. As a result of the conversion, the loan balance decreased to $1 million. The loan and interest payable to Mr. Schwan
amounted to $1.3 million as of June 30, 2023 and December 31, 2022, respectively. No payments were made to Mr. Schwan during 2023 or
2022. Interest expense related to this loan amounted to $18,000 and $17,000 for the three months ended June 30, 2023 and 2022, respectively.
As
of December 31, 2022, the Company had a note payable to Alex Feng for $0.2 million. This loan accrued interest at a rate of 3% and is
subordinated to the Senior Facilities. In accordance with the subordination agreement, payments may be made beginning April 2022 subject
to availability under the revolving line of credit, and the maturity date for this loan was March 2024. Along with certain deposits received
during 2022, this note was converted into common stock during February 2023.
Note
4 - Shareholders’ Equity
Series
A Convertible Preferred Stock
On
January 3, 2020, the Company entered into a stock purchase agreement (as amended on February 24, 2020 and April 13, 2020 (the “LF
Purchase Agreement”)), pursuant to which the Company agreed to issue and sell, and LF International Pte. Ltd., a Singapore private
limited company (“LF International”), which is controlled by Company director, Chairman, President and Chief Executive Officer,
Mr. Yubao Li, agreed to purchase, up to 500,000 shares of the Company’s newly created shares of Series A Preferred Stock (“Series
A Preferred”), with each share of Series A Preferred initially convertible into ten shares of the Company’s common stock,
at a purchase price of $10.00 per share, for aggregate gross proceeds of $5,000,000 (the “LF International Offering”). As
permitted by the Purchase Agreement, the Company may, in its discretion issue up to an additional 200,000 shares of Series A Preferred
for a purchase price of $10.00 per share (the “Additional Shares Offering,” and collectively with the LF International Offering,
the “Offering”). Approximately $1 million of Series A Preferred has been sold, including to an investor which converted an
account receivable of $478,000 owed to the investor by the Company in exchange for 48,200 shares of Series A Preferred. The Company completed
several closings with LF International from January 2020 through June 2020. The majority of the funds received reduced our bank debt.
We issued a total of 400,000 shares of common stock to LF International and, pursuant to the LF Purchase Agreement, changed our name
from CTI Industries Corporation to Yunhong CTI Ltd. LF International had the right to name three directors to serve on our Board. They
were Mr. Yubao Li, Ms. Wan Zhang and Ms. Yaping Zhang. Ms. Wan Zhang and Ms. Yaping Zhang retired from the Board in January 2022.
The
issuance of the Series A Preferred generated a beneficial conversion feature (BCF), which arises when a debt or equity security is issued
with an embedded conversion option that is beneficial to the investor or in the money at inception because the conversion option has
an effective strike price that is less than the market price of the underlying stock at the commitment date. The fair value of the common
stock into which the Series A Preferred was convertible exceeded the allocated purchase price fair value of the Series A Preferred Stock
at the closing dates by approximately $2.5 million as of the closing dates. We recognized this BCF by allocating the intrinsic value
of the conversion option, to additional paid-in capital, resulting in a discount on the Series A Preferred. As the Series A Preferred
is immediately convertible, the Company accreted the discount on the date of issuance. The accretion was recognized as dividend equivalents.
Holders of the Series A Preferred were entitled to receive quarterly dividends at the annual rate of 8% of the stated value ($10 per
share). Such dividends may be paid in cash or in shares of common stock at the Company’s discretion. In the three months ended
June 30, 2023 and 2022 the Company accrued none and $100,000 of these dividends in each period, respectively, as the investor converted
Series A Convertible Preferred Stock into common stock on September 1, 2022. This conversation resulted in the issuance of 5 million
shares of common stock plus an additional approximately 1.3 million shares of common stock representing the accrued dividends.
Series
B Convertible Preferred Stock
In
November 2020, we issued 170,000 shares of Series B Preferred for an aggregate purchase price of $1,500,000. The Series B Preferred have
an initial stated value of $10.00 per share and liquidation preference over common stock. The Series B Preferred is convertible into
shares of our common stock equal to the number of shares determined by dividing the sum of the stated value and any accrued and unpaid
dividends by the conversion price of $1.00. The Series B Preferred accrues dividends at a rate of 8 percent per annum, payable at our
election either in cash or shares of the Company’s common stock. Initially, the Series B Preferred, in whole or part, was redeemable
at the option of the holder (but not mandatorily redeemable) at any time on or after November 30, 2021 for the stated value, plus any
accrued and unpaid dividends and thus was classified as mezzanine equity and initially recognized at fair value of $1.5 million (the
proceeds on the date of issuance). The carrying value as of June 30, 2023 and December 31, 2022 amounted to none and $1,851,000, respectively.
On February 1, 2023, the investor converted Series B Preferred into approximately 1.9 million shares of common stock, including accrued
dividends.
Series
C Convertible Preferred Stock
In
January 2021 we entered into an agreement with a related party, LF International Pte. Ltd. which is controlled by Company director and
Chairman, Mr. Yubao Li, to purchase shares of Series C Preferred stock. We issued 170,000 shares of Series C Preferred for an aggregate
purchase price of $1,500,000. The Series C Preferred have an initial stated value of $10.00 per share and liquidation preference over
common stock. The Series C Preferred is convertible into shares of our common stock equal to the number of shares determined by dividing
the sum of the stated value and any accrued and unpaid dividends by the conversion price of $1.00. The Series C Preferred accrues dividends
at a rate of 8 percent per annum, payable at our election either in cash or shares of the Company’s common stock. The issuance
of the Series C Preferred generated a beneficial conversion feature (BCF), which arises when a debt or equity security is issued with
an embedded conversion option that is beneficial to the investor or in the money at inception because the conversion option has an effective
strike price that is less than the market price of the underlying stock at the commitment date. The fair value of the common stock into
which the Series C Preferred was convertible exceeded the allocated purchase price of the Series C Preferred at the closing dates by
greater than the allocated purchase price. Therefore, the BCF was the purchase price of the Series C Preferred ($1.5 million) and was
allocated to Additional Paid-in Capital, resulting in a discount on the Series C Preferred Stock. As the Series C Preferred Stock is
immediately convertible, the Company accreted the discount on the date of issuance. The accretion to the carrying value of the Series
C Preferred is treated as a deemed dividend, recorded as a charge to Additional Paid in Capital and deducted in computing earnings per
share. On September 1, 2022, the investor converted Series C Preferred into approximately 2 million shares of common stock, including
accrued dividends.
Series
D Convertible Preferred Stock
In
June 2021, the Company received $1.5 million from an unrelated third party as an advance on a proposed sale of Series D Redeemable Convertible
Preferred Stock. As of September 30, 2021, the Company was in the process of negotiating and finalizing the terms of the arrangement.
As the agreement was not finalized as of September 30, 2021, the $1.5 million advance was classified as Advance from Investor within
liabilities on the balance sheet at that time. As of December 31, 2021, the terms had been finalized, the investment was classified as
equity, similar to the prior Convertible Preferred issuances, above. The issuance of the Series D Preferred generated a beneficial conversion
feature (BCF), which arises when a debt or equity security is issued with an embedded conversion option that is beneficial to the investor
or in the money at inception because the conversion option has an effective strike price that is less than the market price of the underlying
stock at the commitment date. The fair value of the common stock into which the Series D Preferred was convertible exceeded the allocated
purchase price fair value of the Series D Preferred Stock at the closing dates by approximately $0.3 million as of the closing dates.
We recognized this BCF by allocating the intrinsic value of the conversion option, to additional paid-in capital, resulting in a discount
on the Series D Preferred. As the Series D Preferred is immediately convertible, the Company accreted the discount on the date of issuance.
The accretion was recognized as dividend equivalents. Holders of the Series D Preferred will be entitled to receive quarterly dividends
at the annual rate of 8% of the stated value ($10 per share). Such dividends may be paid in cash or in shares of common stock at the
Company’s discretion. In addition, 128,000 warrants to purchase the Company’s common stock were issued with respect to this
transaction. These warrants are exercisable until December 1, 2024, at the lower of $1.75 per share or 85% of the variable price based
on the ten day volume weighted average price (“VWAP”) of the Company’s common stock. The value of these warrants was
determined to be $230,000 and recorded as an allocation of paid in capital associated with this transaction. On September 1, 2022, the
investor converted Series D Preferred into approximately 1.8 million shares of common stock including accrued dividends.
Deposits
and Note Conversion to Common Stock
In
connection with the 2021 sale and leaseback transaction of the Company’s primary facility in Lake Barrington, IL, the landlord
advanced rent payments in the form of a note. The balance of that note on December 31, 2022 was approximately $172,000. The note paid
3% interest and was due March 2024. In addition, the same entity made investment deposits during 2022 that were recorded as short term
deposit liabilities. On February 1, 2023, our Board of Directors approved the conversion of these liabilities into common stock at a
rate of approximately 84% of the volume weighted average price (VWAP) of the Company’s common stock during the period these deposits
were received. In total, approximately $0.9 million of liabilities were converted into approximately 1.8 million shares of our common
stock. Upon conversion, both the note and deposit liabilities were fully eliminated.
Investment
Banking Fee
The
Company had an agreement with Garden State Securities beginning December 2019 and ending during 2020, wherein Garden State Securities
sought equity and debt investment opportunities and was due a fee related to successful investment. That agreement had a tail provision
wherein Garden State Securities would be entitled to compensation related to investments from identified parties during a fixed period
of time following the termination of the agreement, which has now expired. Pursuant to negotiation between the parties during April 2023,
it was agreed that a total presentation of 125,000 restricted shares of common stock would result in the final resolution of compensation
due Garden State Securities, including that related to Series C Preferred Stock, subsequently converted to common stock, and that the
agreement and all related potential claims were concluded. The proceeds from this investment were not impacted by this resolution.
Warrants
In
connection with the Series A Offering, in 2020 the Company issued 792,660 warrants to purchase 792,660 shares of the Company’s
common stock for $1 per share. During 2020, warrants to acquire 597,500 shares of common stock were exercised in cash-less exchange for
391,308 shares of the Company’s common stock. In January and February 2021, the remaining warrants to acquire 195,160 shares of
common stock were exercised in a cash-less exchange for 103,104 shares of the Company’s common stock. Additional warrants to acquire
128,000 shares of common stock were issued with respect to the Series D transaction above. These warrants can be exercised for the Company’s
common stock for $1.75 per share, or based on the ten day volume weighted average price (VWAP) of the Company’s common stock.
The
Company has applied the Black-Scholes model to value stock-based awards. That model incorporates various assumptions in the valuation
of stock-based awards relating to the risk-free rate of interest to be applied, the estimated dividend yield and expected volatility
of the Company’s Common Stock. The risk-free rate of interest is the U.S. Treasury yield curve for periods within the expected
term of the option at the time of grant. The expected volatility is based on historical volatility of the Company’s Common Stock.
The
valuation assumptions we have applied to determine the value of warrants granted in 2021 and 2020 were as follows:
|
- |
Historical
stock price volatility: The Company used the weekly closing price to calculate historical annual volatility which was a range from
68% - 167%. |
|
|
|
|
- |
Risk-free
interest rate: The Company bases the risk-free interest rate on the rate payable on US treasury securities with a similar maturity
in effect at the time of the grant, which was a range from .42% - 1.65%. |
|
|
|
|
- |
Expected
life: The expected life of the warrants represents the period of time warrants were expected to be outstanding. The Company used
an expected life of 5 years. |
|
|
|
|
- |
Dividend
yield: The estimate for dividend yield is 0%, as the Company did not issue dividends during 2021 or 2020 and does not expect to do
so in the foreseeable future. |
|
|
|
|
- |
Estimated
forfeitures: When estimating forfeitures, the Company considers historical terminations as well as anticipated retirements. |
A
summary of the Company’s stock warrant activity is as follows:
Schedule of
Company’s Stock Warrant Activity
| |
Shares
under Option | | |
Weighted
Average Exercise Price | |
Balance
at December 31, 2022 | |
| 128,000 | | |
$ | 1.75 | |
Granted | |
| - | | |
| - | |
Cancelled/Expired | |
| - | | |
| - | |
Exercised/Issued | |
| - | | |
| - | |
Outstanding
at June 30, 2023 | |
| 128,000 | | |
| 1.75 | |
| |
| | | |
| | |
Exercisable
at June 30, 2023 | |
| 128,000 | | |
$ | 1.75 | |
As
of June 30, 2023 the Company reserved the following shares of its common stock for the exercise of warrants, and preferred stock:
Schedule
of Reserved Shares of Exercise Warrants
2021
Warrants | |
| 128,000 | |
Shares
reserved as of June 30, 2023 | |
| 128,000 | |
Effective
January 2022, and in accordance with the Employment Agreement of Chief Executive Officer Frank Cesario, a grant of restricted stock was
made in the amount of 250,000 shares. 25,000 shares vested immediately, while the remaining 225,000 are subject to performance conditions
as further detailed in the share grant. Specifically, the restrictions on the remaining 225,000 shares will lapse based on satisfaction
of the following performance goals and objectives and continued employment through the date of meeting such targets:
●
The restrictions on 56,250 shares of the award will lapse and the award will vest when the Company’s trailing-twelve-month EBITDA
equals or exceeds $1 million at any time on or after January 1, 2022.
●
The restrictions on 56,250 shares of the award will lapse and the award will vest in the event the Company’s common shares trade
at or above $5/share for ten or more consecutive trading days.
●
The restrictions on 56,250 shares of the award will lapse and the award will vest when the Company’s operating cash flow, calculated
cumulatively from the date of employment, equals or exceeds $1.5 million. On January 30, 2023, the Compensation Committee determined
this condition had been satisfied.
●
The restrictions on 56,250 shares of the award will lapse and the award will vest in the event the Company is able to refinance its current
lender with a traditional lender on terms and conditions customary for such financing. On August 23, 2022, the Compensation Committee
determined this condition had been satisfied with an amended agreement with the Company’s lender.
During
2022 the Compensation Committee awarded the Chief Operating Officer a grant of 100,000 shares of restricted stock. 20,000 of these shares
vested over a 12 month period while the remaining shares vest 20,000 each based on the performance conditions above.
The
Audit Committee (as defined in the Plan) is responsible for determining when the conditions above have been satisfied. The Company records
compensation expense with each vesting, and records a likelihood of vesting weighted analysis to the extent it has visibility to do so.
Without such visibility, it considers such probability as de minimis until additional information is available.
Note
5 - Legal Proceedings
The
Company may be party to certain lawsuits or claims arising in the normal course of business. The ultimate outcome of these matters is
unknown but, in the opinion of management, we do not believe any of these proceedings will have, individually or in the aggregate, a
material adverse effect upon our financial condition, cash flows or future results of operation.
Note
6 - Inventories
Schedule of Inventories
| |
June
30, 2023 | | |
December
31, 2022 | |
Raw
materials | |
$ | 1,209,000 | | |
$ | 1,457,000 | |
Work
in process | |
| 2,548,000 | | |
| 2,513,000 | |
Finished
goods | |
| 3,882,000 | | |
| 4,355,000 | |
Total
inventories | |
$ | 7,639,000 | | |
$ | 8,325,000 | |
Note
7 - Concentration of Credit Risk
Concentration
of credit risk with respect to trade accounts receivable is generally limited due to the large number of entities comprising the Company’s
customer base. The Company performs ongoing credit evaluations and provides an allowance for potential credit losses against the portion
of accounts receivable which is estimated to be uncollectible. Such losses have historically been within management’s expectations.
During the three and six months ended June 30, 2023 and 2022, there were two customers whose purchases represented more than 10% of the
Company’s consolidated net sales. Sales to these customers for the three and six months ended June 30, 2023 and 2022 are as follows:
Schedule
of Concentration Risk
| |
Three
Months Ended | | |
Three
Months Ended | |
| |
June
30, 2023 | | |
June
30, 2022 | |
Customer | |
Net
Sales | | |
%
of Net Sales | | |
Net
Sales | | |
%
of Net Sales | |
Customer
A | |
$ | 2,347,000 | | |
| 56 | % | |
$ | 1,829,000 | | |
| 41 | % |
Customer
B | |
$ | 668,000 | | |
| 16 | % | |
$ | 1,323,000 | | |
| 30 | % |
| |
Six
Months Ended | | |
Six
Months Ended | |
| |
June
30, 2023 | | |
June
30, 2022 | |
Customer | |
Net
Sales | | |
%
of Net Sales | | |
Net
Sales | | |
%
of Net Sales | |
Customer
A | |
$ | 4,910,000 | | |
| 54 | % | |
$ | 4,331,000 | | |
| 42 | % |
Customer
B | |
$ | 2,320,000 | | |
| 25 | % | |
$ | 2,670,000 | | |
| 26 | % |
As
of June 30, 2023, the total amounts owed to the Company by these customers were approximately $2,455,000 or 83% of the Company’s
consolidated net accounts receivable. The amounts owed at June 30, 2022 by these customers were approximately $2,008,000 or 73% of the
Company’s consolidated net accounts receivable.
Note
8 - Related Party Transactions
John
H. Schwan, who resigned as Chairman of the Board on June 1, 2020, has made loans to the Company which had outstanding balances of $1.3
million as of June 30, 2023 and December 31, 2022, respectively. No payments were made to Mr. Schwan since 2019. Interest expense related
to this loan amounted to $18,000 and $17,000 for the three months end June 30, 2023 and 2022, respectively. Mr. Schwan is the father
of Jana Schwan, the Company’s Chief Operating Officer.
Note
9 - Leases
We
adopted ASC Topic 842 (Leases) on January 1, 2019. In July 2020, the Company entered into a lease agreement for a building through June
2021 (with no extension options). The monthly lease payments were $38,000. The Company made a policy election to not recognize right
of use assets and lease liabilities that arise from leases with an initial term of twelve months or less on the Consolidated Balance
Sheets. However, the Company recognized these lease payments in the Consolidated Statement of Operations on a straight-line basis over
the lease term and variable lease payments in the period in which the expense was incurred. This lease terminated during 2021 and was
replaced with a new lease. In March 2021, the Company entered into a lease agreement for a building through September 2022. This lease
was subsequently extended during March 2022 to extend through December 31, 2025. The monthly lease payments are $35,000. The Company
uses the incremental borrowing rate of 11%.
When
this lease was extended during March 2022, the ROU (right of use) asset increased to $4,277,000, from $3,530,000 at December 31, 2021.
The ROU liabilities also increased to $500,000 (current) and $3,777,000 (noncurrent), from $648,000 and $2,860,000, respectively, as
of December 31, 2021.
Item
2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Forward
Looking Statements
This
Quarterly Report on Form 10-Q includes both historical and “forward-looking statements” within the meaning of Section 21E
of the Securities Exchange Act of 1934, as amended. We have based these forward-looking statements on our current expectations and projections
about future results. Words such as “may,” “should,” “could,” “would,” “expect,”
“plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,”
“continue,” or similar words are intended to identify forward-looking statements, although not all forward-looking statements
contain these words. Although we believe that our opinions and expectations reflected in the forward-looking statements are reasonable,
we cannot guarantee future results, levels of activity, performance or achievements, and our actual results may differ substantially
from the views and expectations set forth in this Quarterly Report on Form 10-Q. We disclaim any intent or obligation to update any forward-looking
statements after the date of this Quarterly Report on Form 10-Q to conform such statements to actual results or to changes in our opinions
or expectations. These forward-looking statements are affected by factors, risks, uncertainties and assumptions that we make, including,
without limitation, those discussed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December
31, 2022 under the heading “Risk Factors.”
Overview
We
produce film products for novelty, packaging and container applications. These products include foil balloons, latex balloons and related
products, films for packaging and custom product applications, and flexible containers for packaging and consumer storage applications.
We produce all of our film products for packaging, container applications and most of our foil balloons at our plant in Lake Barrington,
Illinois. We used to produce our latex balloons and latex products at a majority-owned facility in Guadalajara, Mexico (Flexo Universal,
or Flexo). This facility was sold during October 2021. Now the Company purchases latex balloons from an unrelated vendor and distributes
in the United States, particularly to those customers that prefer a combined solution for foil and latex balloons.. Substantially all
of our film products for packaging and custom product applications are sold to customers in the United States. We market and sell our
novelty items, including balloon-inspired gift items (e.g., balloons and candy arranged to look like a flower bouquet for gifting) and
flexible containers for consumer use primarily in the United States.
September
30, 2021 financing
On
September 30, 2021 (the “Closing Date”), the Company entered into a loan and security agreement (the “Agreement”)
with Line Financial (the “Lender”), which provides for a senior secured financing consisting of a revolving credit facility
(the “Revolving Credit Facility) in an aggregate principal amount of up to $6 million (the “Maximum Revolver Amount”)
and term loan facility (the “Term Loan Facility”) in an aggregate principal amount of $731,250 (“Term Loan Amount”
and, together with the Revolving Credit Facility, the “Senior Facilities”). Proceeds of loans borrowed under the Senior Facilities
were used to repay all amounts outstanding under the Company’s prior Agreements and for the Company’s working capital. The
Senior Facilities are secured by substantially all assets of the Company.
Interest
on the Senior Facilities shall be the prime rate published from time to time published in the Wall Street Journal (8% as of March 31,
2023), plus 1.95% per annum, accruing daily and payable monthly. Interest shall be calculated on the basis of a 360-day year for the
actual number of days elapsed. The Term Loan Facility shall be repaid by the Company to Lender in 48 equal monthly installments of principal
and interest, each in the amount of $15,234, commencing on November 1, 2021, and continuing on the first day of each month thereafter
until the Term Loan Maturity Date (as defined in the Agreement). Also, the Company will pay the Lender collateral monitoring fees of
4.62% of the eligible accounts receivable, inventory, and equipment supporting the Revolving Credit Facility and the Term Loan. In addition,
the Company paid the Lender a loan fee of 1.25% of the Maximum Revolver Amount and the Term Loan Amount upon the execution of the Agreement.
During August 2022 the terms were modified to reduce the collateral monitoring fee to 2.77% and added a provision that barred the Company
from repaying the facility prior to September 2023.
The
Senior Facilities mature on September 30, 2023 and shall automatically be extended for successive periods of one year each, unless the
Company or the Lender gives the other party written notice of termination not less than 90 days prior to the end of such term or renewal
term, as applicable. If the Senior Facilities are renewed, the Company shall pay the Lender a renewal fee of 1.25% of the Maximum Revolver
Amount and the Term Loan Amount upon each renewal on the anniversary of the Closing Date. The Company has the option to prepay the Term
Loan Facility (together with all accrued but unpaid interest and a Term Loan Prepayment Fee (as defined the Agreement) in whole, but
not in part, upon not less than 60 days prior written notice to the Lender.
The
Senior Facilities require that the Company shall, commencing December 31, 2021, maintain Tangible Net Worth of at least $4,000,000 or
greater (“Minimum Tangible Net Worth”). Minimum Tangible Net Worth may be adjusted downward by the Lender, from time to time,
in its sole and absolute discretion, based on the effect of non-cash charges and other factors on the calculation of Tangible Net Worth.
Other debt subordinated to Lender is not considered as a reduction of this calculation. The Company believes it was in compliance with
this covenant during every relevant month, including as of December 31, 2022 and June 30, 2023.
The
Senior Facilities contain certain affirmative and negative covenants that limit the ability of the Company, among other things and subject
to certain significant exceptions, to incur debt or liens, make investments, enter into certain mergers, consolidations, and acquisitions,
pay dividends and make other restricted payments, or make capital expenditures exceeding $1 million in the aggregate in any fiscal year.
We are currently working on having a facility in place when the current facility expires on September 30, 2023.
As
of June 30, 2023 and December 31, 2022, the term loan balance amounted to $0.5 million, which consisted of the principal and interest
payable balance of $0.6 million and deferred financing costs of less than $0.1 million. The balance of the Revolving Line of Credit as
of June 30, 2023 and December 31, 2022 amounted to $4.3 and $2.9 million, respectiv